McKesson Corporation (MCK)
NYSE
Closed
Oct 8, 2026
Day's Range
906.6552 wk Range
723.68Overview - MCK - McKesson Corporation
Key Statistics
Valuation
Enterprise Value
114.76B
P/E (Trailing)
‪24.18‬
P/E (Forward)
‪17.89‬
PEG Ratio
‪-1.36‬
Price / Sales (TTM)
‪0.25‬
Price / Book
‪-82.37‬
EV / EBITDA
‪16.23‬
Profitability
Gross Margin
‪3.49%‬
Profit Margin
‪1.11%‬
Operating Margin
‪1.34%‬
Return on Assets
‪4.74%‬
Return on Equity
‪-570.98%‬
Ownership
Shares Outstanding
116.00M
Float
116.39M
Short % of Shares Outstanding
‪2.49%‬
Held by Insiders
‪0.06%‬
Held by Institutions
‪93.52%‬
Price stats
Beta
‪0.30‬
50-Day Avg
‪876.53‬
200-Day Avg
‪847.02‬
Dividends
Payout Ratio
‪8.80%‬
Frequency
Quarterly
Analyst Consensus
17 analysts
Average price target
‪$ 986.94‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MCK - McKesson Corporation
Peers - MCK - McKesson Corporation
Peer Comparison
Compared with companies in Medical Distribution listed on NYSE.
Profile Summary - MCK - McKesson Corporation
About
McKesson Corporation is a healthcare services company that supports the movement of medicines, medical supplies, and related services across the healthcare system. McKesson Corporation serves pharmacies, hospitals, long-term care facilities, clinics, and other care providers through its pharmaceutical distribution,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
